US Broker Ratings

Thermo Fisher Scientific Inc (TMO) Investor Outlook: Evaluating Growth Potential Amidst a Robust Market Position

Thermo Fisher Scientific Inc (NYSE: TMO) stands as a pillar within the healthcare sector, specifically in the diagnostics and research industry. With a commanding market capitalization of $249.58 billion, this..

Cencora, Inc. (COR) Stock Analysis: Strong Analyst Consensus and Potential 20% Upside for Healthcare Investors

Cencora, Inc. (NYSE: COR), a heavyweight in the healthcare sector, is drawing significant attention from investors, with its impressive market cap of $58.57 billion and a robust position in the..

Abbott Laboratories (ABT) Stock Analysis: A Healthcare Giant with 18.73% Potential Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to capture investor attention with its expansive portfolio and robust market presence. With a market capitalization of $176.43 billion,..

Haleon plc (HLN) Investor Outlook: Analyzing a 28.88% Potential Upside in the Healthcare Sector

Haleon plc (HLN) is capturing the attention of investors with a compelling potential upside of 28.88%, as projected by analysts. This United Kingdom-based healthcare giant, with a substantial market capitalization..

BioNTech SE (BNTX) Stock Analysis: Navigating a 19% Upside Amidst Revenue Challenges

As investors continue to navigate the volatile landscape of biotechnology stocks, BioNTech SE (NASDAQ: BNTX) presents both challenges and opportunities. Headquartered in Mainz, Germany, BioNTech has been at the forefront..

Waters Corporation (WAT) Stock Analysis: Strong Buy Consensus with Promising Growth Potential

Waters Corporation (NYSE: WAT), a prominent player in the Healthcare sector’s Diagnostics & Research industry, is capturing investor attention with its robust market position and promising growth trajectory. Headquartered in..

Dr. Reddy’s Laboratories (RDY) Stock Analysis: Potential Upside with Strategic Global Footprint

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a heavyweight in the healthcare sector, continues to capture investor attention with its global operations in the competitive landscape of generic and specialty drug..

Molina Healthcare Inc (MOH) Stock Analysis: Investor Outlook Amid a 9.57% Potential Upside

Molina Healthcare Inc. (NYSE: MOH) presents an intriguing opportunity for investors looking at the healthcare sector, particularly within the realm of healthcare plans. Headquartered in Long Beach, California, Molina Healthcare..

Royalty Pharma plc (RPRX) Stock Analysis: Unlocking a Potential 11.88% Upside

Royalty Pharma plc (NASDAQ: RPRX) stands out in the biotechnology sector with a compelling business model centered on acquiring biopharmaceutical royalties and funding innovation. With a market capitalization of $33.64..

Genmab A/S (GMAB) Stock Analysis: Strong Buy Ratings and 10.81% Upside Potential

Genmab A/S (NASDAQ: GMAB), a prominent player in the biotechnology sector, continues to captivate investor interest with its promising pipeline and strategic collaborations. Headquartered in Copenhagen, Denmark, Genmab specializes in..

Medtronic plc (MDT) Stock Analysis: Valuation Insights and a Potential 18% Upside

Medtronic plc (MDT), a leader in the healthcare sector, is making waves among investors with its robust performance and promising outlook. Headquartered in Galway, Ireland, Medtronic is a titan in..

Biogen Inc. (BIIB) Stock Analysis: Assessing Growth Potential with a 4.65% Upside

Biogen Inc. (NASDAQ: BIIB), a stalwart in the healthcare sector, primarily operates within the drug manufacturing industry. With a market capitalization of $33.63 billion, Biogen is a formidable player in..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Strong Buy Ratings and 12% Upside Potential

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a venerable name in the healthcare sector, commands attention with its substantial market presence and robust product portfolio. Based in Tel Aviv-Yafo, Israel, Teva..

Amgen Inc. (AMGN) Stock Analysis: Navigating a Competitive Market with Strong Returns

For investors seeking exposure in the healthcare sector, Amgen Inc. (NASDAQ: AMGN) presents a compelling opportunity. As a leading player in the drug manufacturing industry, Amgen’s extensive portfolio of innovative..

Insulet Corporation (PODD) Stock Analysis: Exploring a 26% Potential Upside in the Healthcare Sector

Insulet Corporation (NASDAQ: PODD) is a prominent player in the healthcare sector, specifically within the medical devices industry, with a focus on innovative insulin delivery systems. Headquartered in Acton, Massachusetts,..

IQVIA Holdings (IQV) Stock Analysis: A Healthcare Giant with a 3.4% Upside Potential and Strong Buy Ratings

IQVIA Holdings, Inc. (NYSE: IQV) stands as a titan in the healthcare sector, specializing in diagnostics and research. With a market capitalization of $44.5 billion, IQVIA is a formidable player..

Becton, Dickinson and Company (BDX) Stock Analysis: Potential Upside and Steady Growth Make It a Compelling Buy

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, commands attention from investors with its robust market presence and potential upside. With a market capitalization of $50.07..

The Cooper Companies, Inc. (COO) Stock Analysis: Exploring a 19.56% Potential Upside for Investors

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, particularly in the medical instruments and supplies industry, presents an intriguing opportunity for investors seeking exposure in..

Baxter International Inc. (BAX) Stock Analysis: Evaluating Growth Potential and Analyst Consensus

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, stands at a critical juncture for investors eyeing opportunities within the medical instruments and supplies industry. With a significant..

Natera, Inc. (NTRA) Stock Analysis: Navigating High Growth and Investor Sentiment in the Healthcare Sector

Investors eyeing the healthcare sector may want to pay close attention to Natera, Inc. (NASDAQ: NTRA), a prominent player in the diagnostics and research industry. With a market capitalization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds